Some recent analyst ratings include

• 9/26/2019-
  AbbVie Inc (NYSE:ABBV) gets upgraded to Buy by Citigroup with a price target of $90.00
• 9/12/2019-
  AbbVie Inc (NYSE:ABBV) gets upgraded to Buy by UBS Group with a price target of $79.00
• 6/27/2019-
  AbbVie Inc (NYSE:ABBV) gets upgraded to Peer Perform by Wolfe Research
• 6/26/2019-
  AbbVie Inc (NYSE:ABBV) gets upgraded to Outperform by Svb Leerink with a price target of $88.00
• 5/28/2019-
  AbbVie Inc (NYSE:ABBV) has coverage initiated with a Neutral ➝ Neutral rating and $84.00 price target

• On 9/16/2019 Laura J Schumacher, Vice Chairman, bought 25,000 with an average share price of $70.42 per share and the total transaction amounting to $1,760,500.00.
• On 8/29/2019 Nicholas Donoghoe, SVP, bought 7,525 with an average share price of $66.19 per share and the total transaction amounting to $498,079.75.
• On 8/16/2019 Jeffrey Ryan Stewart, SVP, bought 15,552 with an average share price of $64.44 per share and the total transaction amounting to $1,002,170.88.
• On 8/1/2019 Roxanne S Austin, Director, bought 55,000 with an average share price of $65.86 per share and the total transaction amounting to $3,622,300.00.
• On 7/30/2019 Roxanne S Austin, Director, bought 10,000 with an average share price of $66.35 per share and the total transaction amounting to $663,500.00.
• On 7/29/2019 Henry O Gosebruch, EVP, bought 30,000 with an average share price of $67.28 per share and the total transaction amounting to $2,018,400.00.
• On 6/26/2019 Roxanne S Austin, Director, bought 11,500 with an average share price of $67.50 per share and the total transaction amounting to $776,250.00.

Recent Trading Activity for